Roman Reindl‐Schwaighofer

A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection

Konstantin Doberer, Michael Duerr, Philip F. Halloran et al. · Journal of the American Society of Nephrology · 2020 · 175 citations · Full text

Life Sciences, Immunology, Nephrology +16

Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort

Roman Reindl‐Schwaighofer, Andreas Heinzel, Alexander Kainz et al. · The Lancet · 2019 · 139 citations

Life Sciences, Immunology, Nephrology +17

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients

Roman Reindl‐Schwaighofer, Andreas Heinzel, Manuel Mayrdorfer et al. · JAMA Internal Medicine · 2021 · 126 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients—A prospective observational trial

Konstantin Doberer, Martin Schiemann, Frederik Haupenthal et al. · American Journal of Transplantation · 2020 · 120 citations · Full text

Life Sciences, Infectious Diseases, Nephrology +17

CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection

Konstantin Doberer, Johannes Kläger, Guido A. Gualdoni et al. · Transplantation · 2020 · 115 citations

Life Sciences, Immunology, Pharmacotherapy +17